Pacer Advisors, Inc. Neurocrine Biosciences Inc Transaction History

Pacer Advisors, Inc.

$40.5 Billion
Q4 2024

A detailed history of Pacer Advisors, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 31,837 shares of NBIX stock, worth $4.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

31,837

Previous 28,793 10.57%

Holding current value

$4.67 Million

Previous $3.31 Million 31.11%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$111.62 - $139.44 $339,771 - $424,455	3,044 Added 10.57%	31,837 $4.35 Million
Q3 2024 Nov 12, 2024	SELL	$114.58 - $153.15 $354,854 - $474,305	-3,097 Reduced 9.71%	28,793 $3.31 Million
Q2 2024 Aug 13, 2024	BUY	$130.86 - $143.19 $1.8 Million - $1.97 Million	13,782 Added 76.11%	31,890 $4.39 Million
Q1 2024 May 10, 2024	BUY	$130.4 - $143.74 $456,400 - $503,090	3,500 Added 23.96%	18,108 $2.5 Million
Q4 2023 Jan 16, 2024	BUY	$106.07 - $132.76 $684,151 - $856,301	6,450 Added 79.06%	14,608 $1.92 Million
Q3 2023 Nov 13, 2023	SELL	$94.02 - $117.1 $1.16 Million - $1.45 Million	-12,344 Reduced 60.21%	8,158 $917,000
Q2 2023 Jul 12, 2023	BUY	$89.53 - $104.87 $1.84 Million - $2.15 Million	20,502 New	20,502 $1.93 Million
Q4 2022 Feb 06, 2023	BUY	$106.72 - $127.06 $1.52 Million - $1.81 Million	14,218 Added 338.2%	18,422 $2.2 Million
Q3 2022 Oct 18, 2022	BUY	$92.03 - $107.81 $386,894 - $453,233	4,204 New	4,204 $447,000
Q1 2022 Apr 05, 2022	SELL	$72.45 - $94.81 $887,295 - $1.16 Million	-12,247 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$79.65 - $106.22 $205,576 - $274,153	2,581 Added 26.7%	12,247 $1.04 Million
Q3 2021 Oct 15, 2021	SELL	$86.18 - $99.03 $20,166 - $23,173	-234 Reduced 2.36%	9,666 $927,000
Q2 2021 Jul 21, 2021	BUY	$89.43 - $102.27 $813,902 - $930,759	9,101 Added 1139.05%	9,900 $963,000
Q1 2021 Apr 05, 2021	SELL	$87.57 - $119.4 $57,445 - $78,326	-656 Reduced 45.09%	799 $78,000
Q4 2020 Jan 20, 2021	BUY	$86.91 - $108.33 $47,105 - $58,714	542 Added 59.36%	1,455 $139,000
Q3 2020 Oct 19, 2020	BUY	$96.16 - $135.15 $87,794 - $123,391	913 New	913 $88,000
Q4 2018 Feb 13, 2019	SELL	$68.32 - $124.36 $181,799 - $330,921	-2,661 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $263,119 - $334,886	2,661 New	2,661 $327,000
Q1 2018 May 14, 2018	SELL	$75.88 - $92.43 $146,069 - $177,927	-1,925 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$58.53 - $77.59 $509,620 - $675,576	-8,707 Reduced 81.89%	1,925 $149,000
Q3 2017 Nov 08, 2017	BUY	$47.97 - $61.28 $510,017 - $651,528	10,632	10,632 $652,000

Others Institutions Holding NBIX

# of Institutions

631

Shares Held

93.9M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Neurocrine Biosciences Inc Transaction History